MedTrace Logo

Registry to Evaluate Efficacy of Xience/Promus Versus Cypher in Reducing Late Loss After Stenting

NCT00960648 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3056

Last updated 2026-04-27

No results posted yet for this study

Summary

The objective of this study is to evaluate the safety and long-term effectiveness of coronary stenting with the everolimus-eluting stent (EES) and to determine clinical device and procedural success during commercial use of EES in the real world.

The investigators will compare EES (Xience/Promus, prospective arm) with sirolimus-eluting stent (SES, Cypher, retrospective arm).

Conditions

Interventions

DEVICE

Xience/Promus

Active prospective registration of patients receiving everolimus-eluting stent

DEVICE

Cypher

Retrospective historical controls that received sirolimus-eluting stent

Sponsors & Collaborators

  • Abbott

    collaborator INDUSTRY

  • Boston Scientific Corporation

    collaborator INDUSTRY

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Hyo-Soo Kim, MD,PhD · Seoul National University Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2014-01-31
Completion
2014-01-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00960648 on ClinicalTrials.gov